DAX20.404 ±0,0%ESt504.958 ±-0,0%MSCIW3.845 +0,1%Dow44.149 -0,2%Nas20.035 +1,8%Bitcoin95.561 -0,7%Euro1,0505 +0,1%Öl73,47 -0,2%Gold2.710 -0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T NVIDIA 918422 ABOUT YOU A3CNK4 TUI TUAG50 Rheinmetall 703000 Siemens Energy ENER6Y Amazon 906866 Palantir A2QA4J Bayer BAY001 Mercedes-Benz Group (ex Daimler) 710000 Apple 865985 Volkswagen (VW) vz. 766403 Allianz 840400 Alphabet A (ex Google) A14Y6F Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
EZB-Zinsentscheid im Fokus: DAX knapp höher -- Asiens Börsen schließen im Plus -- Tesla-Aktie nach Rekordhoch weiter gefragt -- Apple, Adobe, BASF, Microsoft im Fokus
Top News
Freundlicher Handel: Euro STOXX 50 mittags freundlich Freundlicher Handel: Euro STOXX 50 mittags freundlich
SLI-Handel aktuell: SLI bewegt sich am Mittag im Plus SLI-Handel aktuell: SLI bewegt sich am Mittag im Plus
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Ste Virbac SA Aktie

NeuKaufenVerkaufen
319,50 EUR -5,00 EUR -1,54 %
STU
325,00 EUR -5,00 EUR -1,52 %
PAR
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.2,70 Mrd. EUR

KGV24,96Div. Rendite0,37%

WKN874929

ISINFR0000031577

SymbolVRBCF

Ste Virbac SA Aktien News

DatumMeistgelesen
GlobeNewswireVIRBAC: current operating income before R&D slightly improving throughout first half of 2023 in percentage of revenue
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 08/2023
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 07/2023
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 06/2023
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 05/2023
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 04/2023
GlobeNewswireVirbac launches a share buyback program
GlobeNewswireVIRBAC - 2023 half-year results: publication postponed to end of September
GlobeNewswireVirbac : Revenue up about 2% during the second quarter and stable at the end of June despite two unfavorable one-off effects throughout the semester
GlobeNewswireRepeat: Virbac reassesses its 2023 growth and Adjusted EBIT1 forecasts
GlobeNewswireVirbac : Public release of Virbac Annual Report at 31 December 2022 (ESEF format)
GlobeNewswireVIRBAC: Slight decline in first-quarter revenue primarily due to a base effect as well as a context of market slowdown
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 03/2023
GlobeNewswireVirbac : Public release of the Year-End Consolidated Accounts at 31 December 2022
GlobeNewswireVIRBAC: 2022 current operating income on the rise at +8.3%, reflecting the momentum of our business over the year in a slowing market
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 02/2023
GlobeNewswireVirbac : Declaration of the number of shares and voting rights 01/2023
GlobeNewswireVIRBAC: Revenue growth at end of September at +7.7% at comparable exchange rates and perimeter (+12.7% at actual rates
GlobeNewswireVirbac: increase in operating income in the first half of 2022 reflecting the dynamism of our business
GlobeNewswireVIRBAC: growth in revenue in the first half of 2022 of +12.0% at comparable exchange rates (+16.4% at real rates), driven by good performance in all areas
GlobeNewswireVirbac : Very strong growth in revenue in the first quarter of 2022 of +16.2% at comparable exchange rates (+19.3% at real rates), driven by good performance in all areas
GlobeNewswireVIRBAC: 2021 operating profit from ordinary activities showed very strong growth, reflecting the excellent dynamism of our business in a rapidly growing market
GlobeNewswireVIRBAC: Exceptional growth in annual revenue of +18.4% at comparable exchange rates and scope (+14.9% at constant rates and real scope), driven by remarkable performance in a very buoyant market

Ste Virbac SA News

Ste Virbac SA News: auf dieser Seite finden Sie alle Ste Virbac SA News und Nachrichten zur Ste Virbac SA Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Ste Virbac SA News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Ste Virbac SA News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.